News
Soleno Therapeutics secures U.S. FDA approval for VYKAT XR to treat hyperphagia in Prader-Willi...
The U.S. Food and Drug Administration (FDA) has approved Soleno Therapeutics' VYKAT XR (diazoxide choline) extended-release tablets, previously referred to as DCCR, for the...
Qfitlia approved as first therapy in US to treat hemophilia A or B with...
The US Food and Drug Administration (FDA) has approved Sanofi's Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce...
Blujepa approved by US FDA for treatment of uncomplicated urinary tract infections
The US Food and Drug Administration (FDA) has approved GSK's Blujepa (gepotidacin) for the treatment of female adults (≥40 kg) and paediatric patients (≥12...
